Clinical Trial Update: Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing insulin-sensitizer therapy on atherothrombotic and inflammatory markers in people with insulin resistance and type 2 diabetes; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mayo Clinic | Conditions: Type 2 Diabetes, Insulin Resistance | Phase 2 | Status: COMPLETED | Results posted: 2013-06-06